About 390 results

ALLMedicine™ Acute Urticaria Center

Research & Reviews  115 results

Nature Reviews. Disease Primers; Kolkhir P, Giménez-Arnau AM et. al.

Sep 16th, 2022 - Urticaria is an inflammatory skin disorder that affects up to 20% of the world population at some point during their life. It presents with wheals, angioedema or both due to activation and degranulation of skin mast cells and the release of histam...

Urticaria relapse after mRNA COVID-19 vaccines in patients affected by chronic spontane...
Dermatologic Therapy; Picone V, Napolitano M et. al.

Sep 16th, 2022 - Urticaria is a disease characterized by wheals and/or angioedema. Chronic spontaneous urticaria (CSU) occurs for longer than 6 weeks and appears independently of any identifiable exogenous stimulus. During the vaccination campaign for Coronavirus ...

Atopic Dermatitis Clinical Presentation

Jul 27th, 2022 - History Incessant pruritus (itchiness) is the central and most debilitating symptom of atopic dermatitis (AD); children often scratch themselves uncontrollably. Although pruritus may be present in the first few weeks of life, parents become more a...

Atopic Dermatitis Medication

Jul 27th, 2022 - Medication Summary The basis of treatment for atopic dermatitis (AD) is to provide moisturization for dryness, allay pruritus, and manage inflammation of the eczematous lesions. Next: Anti-inflammatory agents Class Summary Anti-inflammatory agents...

Cholinergic Urticaria

Jun 6th, 2022 - Practice Essentials Cholinergic urticaria is one of the physical urticarias brought on by a physical stimulus. Although this stimulus might be considered to be heat, the actual precipitating cause is sweating. The definition and diagnostic testing...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  7 results

Modified Xiao-Feng Powder for Chronic Urticaria

Dec 3rd, 2021 - Urticaria is a common skin disorder and 15-25% of people experience at least one attack of urticaria during their lifetime. Urticaria can be divided into acute urticaria (AU) and chronic urticaria (CU) according to the disease duration. CU is clas...

COrticosteroids in acUte uRticAria in emerGency dEpartment

Oct 12th, 2021 - Acute urticaria (hives) is a common skin disease. The prevalence of acute urticaria in life is about 15 to 20% in the general population. It is responsible for a frequent use of emergency departments (ED). The usual treatment is based on early adm...

Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria

Nov 27th, 2019 - This was a multi-center, parallel group, randomized, double-blind, active controlled, Phase III clinical trial of cetirizine injection 10 mg/mL versus diphenhydramine injection 50 mg/mL (Benadryl or generic equivalent) in approximately 256 subject...

Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency

May 11th, 2017 - Acute urticaria is common and affected 12% of population. 400 patients come in department emergency of Toulouse each year and there aren't many studies in literature which evaluate the glucocorticoids treatment. Acute urticaria is pruritic and inc...

Etanercept for the Treatment of Chronic Urticaria

Jun 2nd, 2015 - Chronic urticaria is a common condition which can be debilitating, difficult to treat, and sometimes life-threatening. Approximately 15-25% of the population is affected by urticaria at least once in their lifetime, and chronic urticaria develops ...

see more →

News  22 results

Doctors Can Combat Urticaria Misinformation With Empathy and Facts

Nov 21st, 2022 - Patients suffering from chronic urticaria can easily find bogus causes and treatments online, and providers need to refute the falsehoods with facts, a research letter suggests. "Chronic urticaria can have a major psychological impact, leaving pat...

'Myriad' Dermatologic Reactions After COVID-19 Vaccination

Jul 6th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. GLASGOW — Individuals given COVID-19 vaccination may experience a wide range of dermatologic reactions, some of which may be life-threatening, rev...

Urticaria: An elusive disorder with ‘a high unmet need for treatment’
Doug Brunk

Feb 18th, 2022 - In the clinical experience of Adam Friedman, MD, when patients present with acute urticaria, the culprit is usually food, a drug, or a bug. But in some cases, the trigger remains elusive.

Intravenous Cetirizine Prevents Infusion Reactions From Paclitaxel in Breast Cancer, Other Tumors

Mar 22nd, 2021 - Intravenous (IV) cetirizine (Quzyttir) showed comparable efficacy to IV diphenhydramine for the prevention of infusion reactions (IRs) in patients with cancer who are undergoing treatment with an anti-CD20 antibody or paclitaxel, according to resu...

FDA OKs Cetirizine Injection (Quzyttir ) for Acute Urticaria

Oct 15th, 2019 - The US Food and Drug Administration (FDA) has approved cetirizine hydrochloride for intravenous injection (Quzyttir, JDP Therapeutics) for treatment of acute urticaria in adults and children 6 months of age or older. Quzyttir will be available as ...

see more →

Patient Education  1 results see all →